Comparative Effect of Theipoental and Propofol in IVF Outcome
NCT02377778 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 180
Last updated 2015-03-04
Summary
In this study the aim is to compare the effect of the type of anaesthetic drug used during oocyte retrieval on fertilization rates of oocytes retrieved after ovarian stimulation for in-vitro fertilization.
Conditions
- Subfertility
Interventions
- DRUG
-
Propofol
Propofol intravenous infusion for introduction and maintance of anaesthesia at doses 3-5mg depending on the total time needed for completion of oocyte retrieval
- DRUG
-
Thiopental
Patients will receive thiopental in addition to fentanyl for introduction and maintanance of anaesthesia at doses 7mg. IF required patients will receive a repeat dose of 1-3mg of thiopental depending on the totla time needed to complete oocyte retrieval
Sponsors & Collaborators
-
Aristotle University Of Thessaloniki
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 45 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-01-31
- Primary Completion
- 2013-03-31
- Completion
- 2013-03-31
Countries
- Greece
Study Locations
More Related Trials
-
Corifollitropin Alfa Versus Recombinant Follicle Stimulating Hormone (FSH) in Ovarian Stimulation of Women Undergoing in Vitro Fertilisation
NCT01319695 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Subcutaneous Progesterone Versus Vaginal Progesterone for Endometrial Preparation in Fresh Donated Oocytes Recipients
NCT02363127 ·Status: COMPLETED ·Phase: PHASE4
-
Long Protocol and Freeze All Embryos vs Antagonist Protocol With Fresh Embryo Transfer in PCOS Patients Undergoing ICSI
NCT03118830 ·Status: COMPLETED ·Phase: PHASE4
-
Outcome of Three Controlled Ovarian Hyperstimulation Protocols in Poor Responding Infertility Patients
NCT02293668 ·Status: COMPLETED ·Phase: NA
-
Clomiphene Citrate in Combination With Gonadotropins for Ovarian Stimulation in Women With Poor Ovarian Response.
NCT02237755 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Progesterone Rise in Agonist Versus Antagonist in Vitro Fertilization (IVF) Cycles
NCT01191710 ·Status: UNKNOWN ·Phase: PHASE4
-
Mild Versus Conventional Ovarian Stimulation for Poor Responders Undergoing In Vitro Fertilisation
NCT01319708 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Clinical and Live Birth Rates After Following Long Antagonist Protocol Versus Long Agonist Protocol
NCT03693534 ·Status: UNKNOWN
-
Use of Antagonist Versus Agonist GnRH in Oocyte Recipient Endometrium Preparation
NCT00633347 ·Status: COMPLETED ·Phase: PHASE4
-
Vaginal Versus Combined Use of Progesterone in Fresh IVF/ICSI Cycles
NCT05089383 ·Status: UNKNOWN
-
Efficacy and Safety of Medication Used to Stimulate Ovulation
NCT02715336 ·Status: UNKNOWN ·Phase: PHASE4
-
Comparative Study of Long-acting and Short Acting Triptorelin in PCOS Patients Who Underwent IVF/ICSI
NCT02477566 ·Status: UNKNOWN ·Phase: NA
-
Clinical and Live Birth Rates After Following Long Antagonist Protocol Versus Classical Antagonist Protocol
NCT03684421 ·Status: UNKNOWN
-
Use of Corifolitropin Alfa in Oocyte Donors
NCT02213627 ·Status: UNKNOWN ·Phase: PHASE4
-
OBE001 Phase 2 Dose-finding Study Versus Placebo in Women Undergoing Embryo Transfer in the Context of IVF-ICSI
NCT02310802 ·Status: COMPLETED ·Phase: PHASE2
-
Addition of Prednisolone and Heparin in Patients Undergoing IVF With Failed IVF Cycles
NCT01590173 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Patients' Preference for Subcutaneous or Vaginal Progesterone as Luteal Support in IVF/ICSI Cycles
NCT03181685 ·Status: TERMINATED ·Phase: PHASE4
-
Is the IVF Outcome Dependent on the Time Interval Between hCG Administration and Oocyte Retrieval?
NCT02044445 ·Status: COMPLETED ·Phase: NA
-
A Randomised, Phase II, Comparative Study With a Parallel Control for Evaluating the Efficacy and Safety of Combined Treatment of Lutropin Alpha and Recombinant Human Luteinizing Hormone in the Middle of the Controlled Ovarian Stimulation Follicular Phase in Women With Reduced Ovarian Reserve
NCT01110707 ·Status: COMPLETED ·Phase: PHASE2
-
Patient's Preferences About Subcutaneous or Vaginal Progesterone Administration for Luteal Phase Support
NCT03734770 ·Status: COMPLETED ·Phase: NA
-
Oestradiol Pre-treatment in an Ultrashort Flare GnRH Agonist/GnRH Antagonist Protocol in Poor Responders Undergoing IVF
NCT01798836 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
Administration of GnRH Antagonist to Oocyte Donation Recipients
NCT00635258 ·Status: COMPLETED
-
Ovarian Stimulation With FSH Alone Versus FSH Plus GnRH Antagonist in an Oocyte Donor/Recipient Programme
NCT05759871 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Clinical Study of Recombinant Human Follitropin for Injection Assisted in COH Assisted IVF-ET
NCT03071172 ·Status: UNKNOWN ·Phase: PHASE3
-
Role of Ratio of Progesterone to Number of Follicles as a Prognostic Tool for IntracytoplasmicSperm Injection Outcome
NCT03105323 ·Status: UNKNOWN